語系:
繁體中文
English
說明(常見問題)
圖資館首頁
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
PARP as a therapeutic target
~
Zhang, Jei.
PARP as a therapeutic target
紀錄類型:
書目-電子資源 : Monograph/item
正題名/作者:
PARP as a therapeutic targetedited by Jei Zhang.
其他作者:
Zhang, Jei.
出版者:
Boca Raton, Fla. :CRC Press,c2002.
面頁冊數:
338 p. :ill.
標題:
NAD-ADP-ribosyltransferaseInhibitors
電子資源:
book distributed by CRC Press. Purchase or institutional license may be required for access.
ISBN:
9781420042405 (e-book : PDF)
PARP as a therapeutic target
PARP as a therapeutic target
[electronic resource] /edited by Jei Zhang. - Boca Raton, Fla. :CRC Press,c2002. - 338 p. :ill. - Pharmacology and toxicology. - Pharmacology & toxicology (Boca Raton, Fla.).
Includes bibliographical references and index.
Machine generated contents note: Chapter 1 -- Nervous System Functions of Poly(ADP-Ribose) Polymerase-1 -- Krishna Juluri, Hyo Chol Ha, and Solomon H. Snyder -- Chapter 2 -- Role of Poly(ADP-Ribose) Polymerase- 1 in Neurologic Disorders -- Marc E Poitras, Valina L. Dawson, and Ted M. Dawson -- Chapter 3 -- Involvement of PARP-1 and Poly(ADP-Ribosyl)ation in the Maintenance of -- Genomic Stability -- Cynthia M. Simbulan-Rosenthal, Dean S. Rosenthal, Bassem H. Haddad, -- Danith Ly, Jie Zhang, and Mark E. Smulson -- Chapter 4 -- Functional Testing of Human PARP in Proliferation, Endotoxic Shock, and -- Radiosensitivity: A Genetic Rescue Study. -- Zdenko Herceg, Virginie Petrilli, Anton Wutz, Berhard Auer, Marie-Pierre Cros, -- and Zhao-Qi Wang -- Chapter 5 -- PARP Inhibitors as Neuroprotective Agents for Brain Injury -- Joel H. Greenberg, Michelle C. LaPlaca, and Tracy K. Mclntosh -- Chapter 6 -- PARP Inhibitors and Cardioprotection -- Christoph Thiemermann, Nicole Wayman, Michelle C. McDonald, and -- Prabal Kumar Chatterjee -- Chapter 7 -- Neuroprotection of the Retina with 3-Aminobenzamide, a PARP Inhibitor -- Tim T Lam -- Chapter 8 -- Poly(ADP-Ribose) Polymerase Inhibitors and Acute Renal Failure -- Prabal Kumar Chatterjee and Christoph Thiemermann -- Chapter 9 -- Role of Poly(ADP-Ribose) Polymerase Activation in the Pathogenesis of Shock and Inflammation -- Csaba Szabd -- Chapter 10 -- Clinical Development of the Nicotinamides and Benzamides Involving PARP as a Molecular Target. -- Ronald W. Pero, Anders Olsson, Hanna Lindgren, and Tomas Leanderson -- Chapter 11 -- Chemoprotective Effect of a Novel PARP Inhibitor -- Gyorgy Rabloczky, Laszlo Jaszlits, Gyorgy Bardos, Balazs Sumegi, Kalman Tory, -- Ildiko Racz, Beatrix Farkas, Attila Sandor, Zoltan Berente, Erzsebet Osz, -- Judit Szilvassy, Istvan Sziklai, Sandor Bernath, and Peter Literati Nagy -- Chapter 12 -- Beneficial Effect of GPI 6150 Treatment in Multiple Animal Models of Diseases -- Jie Zhang -- Chapter 13 -- Protecting Effect of PARP Inhibition on Ultraviolet Light-Induced Skin Damage -- Beatrix Farkas, Balazs Sumegi, Gyorgy Rabloczky, Bela Csete, Balazs Hodosi, -- Marta Magyarlaki, Sandor Bernath, and Peter Literati Nagy -- Chapter 14 -- Role of Poly(ADP-Ribose) Polymerase Activation in the Pathogenesis of Diabetes Mellitus and Diabetic Vascular Dysfunction. -- Jon G. Mabley, Ldszlo Virdg, and Csaba Szabd -- Chapter 15 -- Therapeutic Targeting of the PARPs: Future Challenges, Future Opportunities -- Myron K. Jacobson and Elaine L. Jacobson.
Mode of access: World Wide Web.
ISBN: 9781420042405 (e-book : PDF)Subjects--Topical Terms:
301695
NAD-ADP-ribosyltransferase
--InhibitorsIndex Terms--Genre/Form:
214472
Electronic books.
Dewey Class. No.: 615/.35
PARP as a therapeutic target
LDR
:03621cmm 2200301 a 4500
001
277021
003
FlBoTFG
005
20090717103237.0
006
a s
007
cru
008
110120s2002 flua b 001 0 eng
020
$a
9781420042405 (e-book : PDF)
020
$a
9780849300738
035
$a
CRC000E0073PDF
040
$a
FlBoTFG
$c
FlBoTFG
082
0 0
$a
615/.35
$2
21
090
$a
RM666.E548
$b
P37 2002
092
$a
615.35
$b
P257
245
0 0
$a
PARP as a therapeutic target
$h
[electronic resource] /
$c
edited by Jei Zhang.
260
$a
Boca Raton, Fla. :
$b
CRC Press,
$c
c2002.
300
$a
338 p. :
$b
ill.
490
1
$a
Pharmacology and toxicology
504
$a
Includes bibliographical references and index.
505
8
$a
Machine generated contents note: Chapter 1 -- Nervous System Functions of Poly(ADP-Ribose) Polymerase-1 -- Krishna Juluri, Hyo Chol Ha, and Solomon H. Snyder -- Chapter 2 -- Role of Poly(ADP-Ribose) Polymerase- 1 in Neurologic Disorders -- Marc E Poitras, Valina L. Dawson, and Ted M. Dawson -- Chapter 3 -- Involvement of PARP-1 and Poly(ADP-Ribosyl)ation in the Maintenance of -- Genomic Stability -- Cynthia M. Simbulan-Rosenthal, Dean S. Rosenthal, Bassem H. Haddad, -- Danith Ly, Jie Zhang, and Mark E. Smulson -- Chapter 4 -- Functional Testing of Human PARP in Proliferation, Endotoxic Shock, and -- Radiosensitivity: A Genetic Rescue Study. -- Zdenko Herceg, Virginie Petrilli, Anton Wutz, Berhard Auer, Marie-Pierre Cros, -- and Zhao-Qi Wang -- Chapter 5 -- PARP Inhibitors as Neuroprotective Agents for Brain Injury -- Joel H. Greenberg, Michelle C. LaPlaca, and Tracy K. Mclntosh -- Chapter 6 -- PARP Inhibitors and Cardioprotection -- Christoph Thiemermann, Nicole Wayman, Michelle C. McDonald, and -- Prabal Kumar Chatterjee -- Chapter 7 -- Neuroprotection of the Retina with 3-Aminobenzamide, a PARP Inhibitor -- Tim T Lam -- Chapter 8 -- Poly(ADP-Ribose) Polymerase Inhibitors and Acute Renal Failure -- Prabal Kumar Chatterjee and Christoph Thiemermann -- Chapter 9 -- Role of Poly(ADP-Ribose) Polymerase Activation in the Pathogenesis of Shock and Inflammation -- Csaba Szabd -- Chapter 10 -- Clinical Development of the Nicotinamides and Benzamides Involving PARP as a Molecular Target. -- Ronald W. Pero, Anders Olsson, Hanna Lindgren, and Tomas Leanderson -- Chapter 11 -- Chemoprotective Effect of a Novel PARP Inhibitor -- Gyorgy Rabloczky, Laszlo Jaszlits, Gyorgy Bardos, Balazs Sumegi, Kalman Tory, -- Ildiko Racz, Beatrix Farkas, Attila Sandor, Zoltan Berente, Erzsebet Osz, -- Judit Szilvassy, Istvan Sziklai, Sandor Bernath, and Peter Literati Nagy -- Chapter 12 -- Beneficial Effect of GPI 6150 Treatment in Multiple Animal Models of Diseases -- Jie Zhang -- Chapter 13 -- Protecting Effect of PARP Inhibition on Ultraviolet Light-Induced Skin Damage -- Beatrix Farkas, Balazs Sumegi, Gyorgy Rabloczky, Bela Csete, Balazs Hodosi, -- Marta Magyarlaki, Sandor Bernath, and Peter Literati Nagy -- Chapter 14 -- Role of Poly(ADP-Ribose) Polymerase Activation in the Pathogenesis of Diabetes Mellitus and Diabetic Vascular Dysfunction. -- Jon G. Mabley, Ldszlo Virdg, and Csaba Szabd -- Chapter 15 -- Therapeutic Targeting of the PARPs: Future Challenges, Future Opportunities -- Myron K. Jacobson and Elaine L. Jacobson.
530
$a
Also available in print edition.
$b
CRC Press (http://www.crcpress.com)
538
$a
Mode of access: World Wide Web.
650
0
$a
NAD-ADP-ribosyltransferase
$x
Inhibitors
$x
Therapeutic use
$x
Testing.
$3
301695
655
7
$a
Electronic books.
$2
local.
$3
214472
700
1
$a
Zhang, Jei.
$3
301694
776
$z
9780849300738
830
0
$a
Pharmacology & toxicology (Boca Raton, Fla.)
$3
188791
856
4 0
$u
http://marc.crcnetbase.com/ISBN/9781420042405
$q
application/PDF
$z
book distributed by CRC Press. Purchase or institutional license may be required for access.
945
$a
URL added - 2010/03/12
筆 0 讀者評論
全部
電子館藏
館藏
1 筆 • 頁數 1 •
1
條碼號
館藏地
館藏流通類別
資料類型
索書號
使用類型
借閱狀態
預約狀態
備註欄
附件
000000020954
電子館藏
1圖書
電子書
EB RM666.E548 P37 2002 c2002
一般使用(Normal)
在架
0
1 筆 • 頁數 1 •
1
多媒體
多媒體檔案
http://marc.crcnetbase.com/ISBN/9781420042405
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入